C02YYZZ
Tomographic (Tomo) Nuclear Medicine Imaging Central Nervous System to None with None, Other Radionuclide Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | C Nuclear Medicine |
| Body System | 0 Central Nervous System |
| Operation | 2 Tomographic (Tomo) Nuclear Medicine Imaging |
| Body Part | Y Central Nervous System |
| Approach | Y Other Radionuclide |
| Device | Z None |
| Qualifier | Z None |
Operation Definition
Introduction of radioactive materials into the body for three dimensional display of images developed from the capture of radioactive emissions
Procedure Overview
Tomographic nuclear medicine imaging of the central nervous system, commonly known as brain SPECT (single photon emission computed tomography), involves injecting a small amount of a radioactive tracer into the bloodstream and then rotating a camera around the head to build a three-dimensional picture of blood flow or metabolic activity inside the brain. Because the tracer distributes according to how much blood or activity is reaching different regions, the resulting images can reveal areas that are underperforming even when a standard CT or MRI looks structurally normal.
Physicians order these scans to evaluate seizure disorders (identifying the region where seizures originate), to assess suspected dementia when the type is unclear, to investigate blood flow after a stroke, and occasionally to help confirm brain death. The scan itself is painless; the tracer is given by injection and the imaging table simply rotates a detector around the patient over roughly 20-40 minutes.
Anatomy & Axis Detail
Central Nervous System
This value is used for tomographic nuclear medicine imaging of central nervous system structures beyond the brain and cerebrospinal fluid, capturing studies where SPECT reconstruction is applied to another CNS target not separately classified. Given how broadly the central nervous system is defined, the underlying radiotracer and its physiologic target, whether a neurotransmitter receptor, an inflammatory marker, or another process, determine the clinical purpose of the study far more than the general body part label does. As with the corresponding planar code, this should only be used when no more specific CNS body part value applies, and the report should clearly state which structure was imaged so the coding reflects the study actually performed rather than defaulting to the general category.
Radionuclide: Other Radionuclide
Other Radionuclide is used when a nuclear medicine study employs a radioactive tracer that does not correspond to one of the specifically named isotope values in this axis, such as an uncommon or newer radiopharmaceutical. It functions as a catch-all so the procedure can still be coded precisely by section and root operation even when the exact tracer lacks its own dedicated code value.
Coding & Documentation
A code from this family is assigned when documentation confirms a rotational (tomographic) acquisition rather than a single flat image, and specifies the radioactive tracer administered, since the qualifier reflects the substance used (e.g., technetium-99m HMPAO for perfusion studies). Supporting documentation should name the tracer, confirm the SPECT technique, and identify the CNS structure imaged.
The most frequent assignment errors are confusing this root operation with PET imaging when the report only says "nuclear brain scan" without stating the modality, and defaulting to a planar imaging code when the physician actually performed a rotational SPECT acquisition. Coders should also avoid assuming a tracer from the clinical indication alone; the radiopharmaceutical must be explicitly documented.